A quick peek into the report
Table of Contents
1.1 Key Questions Answered in the Report:
2.1 EV-Based Liquid Biopsy Market: Research Methodology
2.2 Primary Data Sources
2.3 Secondary Data Sources
2.4 Market Estimation Model
2.5 Criteria for Company Profiling
3.1 Market Introduction
3.2 Current and Future State of EV-Based Liquid Biopsy in Industries
3.3 Current Market Size and Growth Potential, $Million, 2022-2032
3.4 COVID-19 Impact on EV-based Liquid Biopsy Market
3.4.1 Impact on Operations
3.4.2 COVID-19 Impact: Current Scenario of the Market
4.1 Overview
4.1.1 Evs Introduction
4.2 Isolation Methods
4.2.1 EV Isolation Techniques Utilizing Ultracentrifugation Methods
4.2.1.1 Differential Ultracentrifugation
4.2.1.2 Density Gradient Centrifugation
4.2.1.3 Moving Zone or Rate-Zonal Centrifugation
4.2.1.4 Isopycnic Centrifugation
4.2.2 EV Isolation Techniques Utilizing Size-Based Methods
4.2.2.1 Ultrafiltration
4.2.2.2 Sequential Filtration
4.2.2.3 Size Exclusion Chromatography (SEC)
4.2.2.4 Flow Field-Flow Fractionation (FFFF)
4.2.2.5 Hydrostatic Filtration Dialysis (HFD)
4.2.3 EV Isolation Techniques Utilizing Immunoaffinity Methods
4.2.3.1 Enzyme-Linked Immunosorbent Assay (ELISA)
4.2.3.2 Magneto-Immunoprecipitation
4.2.4 EV Isolation Techniques Utilizing Precipitation Methods
4.2.4.1 Polyethylene Glycol (PEG) Precipitation
4.2.4.2 Lectin Induced Agglutination
4.2.5 EV Isolation Techniques Utilizing Microfluidic Technology
4.2.6 EV Isolation Techniques Utilizing Commercial Kits
4.2.7 Advantages and Disadvantages of the EV Isolation Methods
4.2.8 Novel Approaches for Exosome Isolation
4.3 Analysis Methods
4.3.1 Advantages and Disadvantages of Analysis Methods for Evs
5.1 Overview
5.2 Asia-Pacific
5.2.1 China
5.2.2 Japan
5.2.3 India
5.2.4 South Korea
5.2.5 Australia
5.2.6 Singapore
5.2.7 Rest-of-Asia-Pacific
6.1 Company Overview
6.1.1 Horiba Ltd.
6.1.1.1 Company Overview
6.1.1.2 Role of Horiba Ltd. in the EV-Based Liquid Biopsy Market
6.1.1.3 Major Products: Key Specifications
6.1.1.4 Key Competitors
6.1.1.5 Analyst Perspective
6.1.2 Takara Bio Inc.
6.1.2.1 Company Overview
6.1.2.2 Role of Takara Bio Inc. in the EV-Based Liquid Biopsy Market
6.1.2.3 Major Products: Key Specifications
6.1.2.4 Key Competitors
6.1.2.5 Analyst Perspective
6.1.3 Sample Company
6.1.3.1 Overview
6.1.3.2 Top Products / Product Portfolio
6.1.3.3 Top Competitors
6.1.3.4 Target Customers
6.1.3.5 Key Personnel
6.1.3.6 Analyst View
6.1.3.7 Market Share
6.1.4 Sample Company
6.1.4.1 Overview
6.1.4.2 Top Products / Product Portfolio
6.1.4.3 Top Competitors
6.1.4.4 Target Customers
6.1.4.5 Key Personnel
6.1.4.6 Analyst View
6.1.4.7 Market Share
6.1.5 Sample Company
6.1.5.1 Overview
6.1.5.2 Top Products / Product Portfolio
6.1.5.3 Top Competitors
6.1.5.4 Target Customers
6.1.5.5 Key Personnel
6.1.5.6 Analyst View
6.1.5.7 Market Share
6.1.6 Sample Company
6.1.6.1 Overview
6.1.6.2 Top Products / Product Portfolio
6.1.6.3 Top Competitors
6.1.6.4 Target Customers
6.1.6.5 Key Personnel
6.1.6.6 Analyst View
6.1.6.7 Market Share
6.1.7 Sample Company
6.1.7.1 Overview
6.1.7.2 Top Products / Product Portfolio
6.1.7.3 Top Competitors
Table 1: Current and Future State of EV-Based Liquid Biopsy in Industries
Table 2: Example of Few Commercial Kits Available for EV Isolation
Table 3: Advantages and Disadvantages of the EV Isolation Methods
Table 4: Emerging Methods for the Isolation of Exosomes
Table 5: Advantages and Disadvantages of Analysis Methods for Evs
Figure 1: EV-Based Liquid Biopsy Market (by Region), 2022
Figure 2: EV-Based Liquid Biopsy Market Methodology
Figure 3: Primary Research Methodology
Figure 4: Bottom-Up Approach (Segment-Wise Analysis)
Figure 5: Top-Down Approach (Segment-Wise Analysis)
Figure 6: Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 7: Subtypes of Evs
Figure 8: Methods of EV-Isolation from Biofluids
Figure 9: Workflow of Differential Ultracentrifugation for Exosome Isolation
Figure 10: Methods of EV-Analysis
Figure 11: EV-Based Liquid Biopsy Market Snapshot (by Region)
Figure 12: EV-Based Liquid Biopsy Market (by Region), $Million, 2022-2032
Figure 13: Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 14: Asia-Pacific: Market Dynamics
Figure 15: Asia-Pacific EV-Based Liquid Biopsy Market (by Country), $Million, 2022-2032
Figure 16: China EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 17: Japan EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 18: India EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 19: South Korea EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 20: Australia EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 21: Singapore EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 22: Rest-of-Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
Figure 23: Total Number of Companies Profiled
Figure 24: Horiba Ltd.: Product Portfolio
Figure 25: Takara Bio Inc.: Product Portfolio
Asia-Pacific EV-Based Liquid Biopsy Market Report Coverage
|
Asia-Pacific EV-Based Liquid Biopsy Market |
|||
|
Base Year |
2022 |
Market Size in 2023 |
XX |
|
Forecast Period |
2023-2033 |
Value Projection and Estimation by 2033 |
XX |
|
CAGR During Forecast Period |
21.64% |
Number of Pages |
XX |
| Number of Tables | 66 | Number of Figures |
22 |
The global and Asia-Pacific unmanned aerial system (UAS) market comprises key players who have established themselves thoroughly and have the proper understanding of the market, accompanied by start-ups who are looking forward to establishing themselves in this highly competitive market. In 2022, the global and Asia-Pacific unmanned aerial system (UAS) market was dominated by established players, accounting for 61% of the market share, whereas start-ups managed to capture 39% of the market.
Some prominent names established in this market are:
Horiba Ltd
Takara Inc
How can this report add value to the Organization ?
Growth/Marketing Strategy: EV-based liquid biopsy has tremendous growth potential due to its ability to revolutionize non-invasive cancer detection and monitoring. By analyzing the cargo of EVs, researchers can gain insights into the presence, type, and characteristics of tumors without directly accessing the tumor site.
Competitive Strategy: Key players in the APAC EV-based liquid biopsy market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC EV-based liquid biopsy market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.
Asia-Pacific EV-Based Liquid Biopsy Market Overview
Introduction to Asia-Pacific EV-Based Liquid Biopsy Market
The Asia-Pacific EV-based liquid biopsy market is expected to reach $74.75 million by 2032 from $12.82 million in 2023, at a CAGR of 21.64% during the forecast period. The market for EV-based liquid biopsy is anticipated to see growth propelled by continuous technological progress, rising acceptance by healthcare providers, and an increasing emphasis on personalized medical approaches.
Market Introduction
The Asia-Pacific (APAC) region is witnessing significant growth in the EV-based liquid biopsy market. This expansion is primarily attributed to ongoing advancements in healthcare technology and the increasing adoption of liquid biopsy techniques by healthcare providers across the region. Liquid biopsies are gaining prominence as a non-invasive method for early cancer detection and monitoring treatment response, aligning with the growing focus on personalized medicine in the APAC healthcare landscape. Countries like China, Japan, and South Korea are at the forefront of this trend, with a surge in research and development activities and the incorporation of advanced technologies into healthcare systems. Additionally, the region's large and diverse population offers a substantial patient pool for liquid biopsy applications. As a result, the APAC EV-based liquid biopsy market is poised for significant growth, presenting lucrative opportunities for healthcare companies and stakeholders in the region's dynamic healthcare sector.
Market Segmentation:
Segmentation 1: by Country
• China
• Japan
• South Korea
• Australia
• India
• Singapore
• Rest-of-Asia-Pacific
Asia-Pacific EV-Based Liquid Biopsy Market
Analysis and Forecast